Natco Pharma board to consider unaudited financial results

05 Nov 2015 Evaluate

Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on November 13, 2015, to consider the unaudited financial results for the quarter and half year ended September 30, 2015 (Q2) and related matters, and to fix record date for Sub-Division of 1 Equity Share of face value of Rs 10 each into 5 Equity Shares of Rs 2 Each. Further, the Company has informed that Trading Window for dealing in the securities of the Company will be closed from November 05, 2015 to November 15, 2015.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

898.80 -34.80 (-3.73%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×